节点文献
乙肝相关肝癌抗病毒治疗的研究现状
Research Status of Anti-viral Therapy for Hepatitis B Related Hepatocellular Carcinoma
【摘要】 HCC是常见的恶性肿瘤之一,HBV感染与HCC的发生及预后密切相关。有效的抗病毒治疗,可降低HBV相关HCC的发生率,亦可提高患者的生存率及减少复发率,从而改善患者的生存质量。本文就抗病毒治疗对HBV相关HCC的发病、生存率及复发率的影响进行阐述。
【Abstract】 HCC is one of the common malignant tumors, HBV infection is closely related to the occurrence and prognosis of HCC. Effective antiviral therapy can reduce the incidence of HBV related HCC, and improve the survival rate and recurrence rate of patients, thus improving the quality of life of patients. This article were reviewed the effects of antiviral therapy on the incidence, survival rate and recurrence rate of HBV related HCC.
【关键词】 肝细胞癌;
肝炎病毒;
乙型;
抗病毒治疗;
生存率;
复发率;
【Key words】 Hepatocellular carcinoma; Hepatitis virus; Hepatitis B; Antiviral therapy; Survival rate; Recurernce rate;
【Key words】 Hepatocellular carcinoma; Hepatitis virus; Hepatitis B; Antiviral therapy; Survival rate; Recurernce rate;
- 【文献出处】 世界最新医学信息文摘 ,World Latest Medicine Information , 编辑部邮箱 ,2018年38期
- 【分类号】R512.62;R735.7
- 【被引频次】3
- 【下载频次】302